Outcome of Tribunal Convened meeting of Equity shareholders of Mangalam Drugs and Organics Limited held on 12th August 2025 at 12:30p.m.
MANGALAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Drugs & Organics Limited held an NCLT-convened meeting of its equity shareholders on August 12, 2025, via video conferencing from 12:39 PM to 1:05 PM. The sole agenda was to seek shareholder approval for a Scheme of Merger by Absorption, under which Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited will merge into Mangalam Drugs & Organics Limited, under Sections 230–232 of the Companies Act, 2013. The meeting was ordered by the NCLT Mumbai Bench on June 30, 2025, and BSE had already issued its observation letter on January 1, 2025. Voting was conducted through NSDL's remote e-voting and e-voting during the meeting, and the Scrutinizer's consolidated report on the voting results is yet to be submitted to the stock exchanges.
This is a procedural step toward completing the merger scheme. The actual voting outcome is not yet disclosed — investors should wait for the Scrutinizer's Report to know whether shareholders have approved the merger. If approved, it could lead to consolidation and restructuring of the company's pharmaceutical operations.